Botanical soothing care
Purslane extract adds botanical soothing care, while bisabolol helps care for the skin barrier, bringing comfort to your brightening routine.
Facial careFacial care
Brighter-looking skin. A gentler feel.
Purslane extract and bisabolol bring soothing care together with 5% niacinamide and tranexamic acid to help improve the look of dullness and uneven tone. A fine, lightweight cream that balances brightening care with everyday comfort.
Images are for reference. Actual packaging may vary.
Product overview
Bring brightening and dark spot care into your daily cream step. 5% niacinamide pairs with tranexamic acid to help improve the appearance of dullness and uneven tone for a clearer, more radiant-looking complexion.
Purslane extract and bisabolol complement the formula with soothing and barrier care. The lightweight, easily absorbed texture fits into morning and evening routines, keeping comfort part of your brightening care.
HERBPIN / 01
Brighter-looking skin. A gentler feel.
Purslane extract adds botanical soothing care, while bisabolol helps care for the skin barrier, bringing comfort to your brightening routine.
5% niacinamide with tranexamic acid helps improve the appearance of dullness and uneven tone as part of targeted dark spot care.
A fine cream texture feels light and absorbs easily, making it a comfortable step in morning and evening skincare.
HERBPIN / CARE IN FOCUS
Bring dark-spot and brightening care into your daily moisturising routine for a more even-looking complexion.





Application and skin-tone changes are illustrative, not measured results. Individual experiences vary.
HERBPIN / FORMULA
Soothing care meets brightening ingredients for a more even-looking tone and a comfortable feel.
A botanical ingredient for soothing care, helping keep daily skincare comfortable.
Complements soothing care and helps support the skin barrier while you care for an even-looking tone.
Combines brightening and dark spot care to help improve the appearance of dullness and uneven tone.
HERBPIN / EVIDENCE
Follow the gradual changes in skin tone. A four-week human efficacy study completed by 30 participants supported the product’s spot-reducing and brightening efficacy under the study conditions.
Mean change in ITA°
| Observation | Product ΔITA° | Untreated control ΔITA° | Product ΔMI | Untreated control ΔMI |
|---|---|---|---|---|
| Week 1 | +0.41 | +0.02 | −4.67 | +0.01 |
| Week 2 | +1.73 | +0.03 | −15.69 | −0.90 |
| Week 3 | +3.40 | +0.12 | −30.19 | −2.44 |
| Week 4 | +5.85 | +0.59 | −52.04 | −3.67 |
Guangdong Atlas Testing Technology Co., Ltd., report GT03502024380452; efficacy testing completed 4 September 2024. Thirty participants aged 20–58 were assessed using a UV-induced pigmentation model on the legs, with untreated and 7% vitamin C positive controls. The table shows mean changes from baseline. Higher ITA° indicates lighter skin colour; lower MI indicates a lower melanin index. At week 4, product ΔITA° was +5.85 ± 1.44 and ΔMI was −52.04 ± 13.73; p<0.05 versus untreated control. These controlled-study findings do not predict every person’s everyday results.
HERBPIN / FILM
Take a closer look at the brightening cream and its fine, lightweight texture.
Individual experiences and results vary. Follow the product directions.
Facial care
Read the complete ingredient list and directions before use, and choose care that suits your skin.
Include the cream in your morning and evening facial routine, following the product directions.
Use the packaging directions to decide the amount, application order and frequency within your routine.
Choose a routine that suits how your skin feels. Stop use if discomfort occurs.
PRODUCT DOCUMENTS
Brightening cream · Special cosmetic registration国妆特字20251911 · Spot-reducing/whitening category. Approved 5 March 2025; valid until 4 March 2030.Enlarge image
Brightening efficacy & safety testingReports from Guangdong Atlas Testing Technology Co., Ltd. and Kangzheng Testing Services Co., Ltd., including human efficacy, patch testing and physicochemical checks.Enlarge image Issued by China’s National Medical Products Administration (NMPA). The certificate expressly states that registration is not an endorsement of the product’s claimed efficacy.